KRT-232 (AMG 232)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for KRT-232 (AMG 232), covering 2026-02-10 to 2026-02-10. Get the full timeline:
Most recent: Clinical Trial Update: Testing the Addition of KRT-232 (AMG 232) to Usual Chemotherapy for Relapsed Multiple Myeloma [Phase 1]